Elutia regains Nasdaq compliance, shares continue to trade under ELUT.

Elutia Inc., a pioneer in drug-eluting biomatrix technologies, has regained compliance with Nasdaq listing requirements. The company received notice from Nasdaq that it has met the minimum bid price requirement and the minimum market value of listed securities requirement. As a result, Elutia's Class A common stock will continue to be listed and traded on the Nasdaq Capital Market under the symbol "ELUT."